Document is current

Any future updates will be listed below

A preclinical study on the efficacy and safety of a new vaccine against Coxsackievirus B1 reveals no risk for accelerated diabetes development in mouse models

Crossref DOI link: https://doi.org/10.1007/s00125-014-3436-0

Published Online: 2014-11-05

Published Print: 2015-02

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark